Trial intelligence / Profile preview

EGF Ointment for Solar Lentigines

NCT04704245Completed

Sponsor
Hallym University Kangnam Sacred Heart Hospital
Start
Jul 2017
Primary completion
Sep 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in solar lentigines comparing EGF ointment group with Vehicle ointment group (2 arms). Primary endpoint: Change of pigmentation by physician's assessment at 8 weeks. Started Jul 2017; status: completed.

02

Drugs

nepidermin
03

Conditions

solar lentigines

Beyond the preview

Go deeper on NCT04704245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04704245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call